Shaanxi Meibang Pharmaceutical Group Co Ltd
Shaanxi Meibang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, sale, and agricultural technology promotion, and service of pesticide products in China and internationally. The company offers pesticides, fungicides, herbicides, plant growth regulators, fertilizers, and microbial fertilizers. It is also involved in sale of agricu… Read more
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.246x
Based on the latest financial reports, Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a cash flow conversion efficiency ratio of 0.246x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥281.88 Million) by net assets (CN¥1.15 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shaanxi Meibang Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Shaanxi Meibang Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shaanxi Meibang Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shaanxi Meibang Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mnc Investama Tbk
JK:BHIT
|
0.006x |
|
Basso Industry Corp
TW:1527
|
0.014x |
|
Israel Discount Bank Ltd
TA:DSCT
|
0.120x |
|
SOHO China Limited
PINK:SOHOF
|
0.005x |
|
RF Industries Ltd
NASDAQ:RFIL
|
0.060x |
|
Dongnan Electronics Co. Ltd. A
SHE:301359
|
N/A |
|
INTERGRATED DIA.H DL 025
F:8I8
|
N/A |
|
Century Therapeutics Inc
NASDAQ:IPSC
|
-0.145x |
Annual Cash Flow Conversion Efficiency for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of Shaanxi Meibang Pharmaceutical Group Co Ltd from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.12 Billion | CN¥280.40 Million | 0.249x | -17.03% |
| 2023-12-31 | CN¥1.11 Billion | CN¥334.79 Million | 0.300x | +158.23% |
| 2022-12-31 | CN¥1.09 Billion | CN¥126.41 Million | 0.116x | +203.46% |
| 2021-12-31 | CN¥966.95 Million | CN¥-108.75 Million | -0.112x | -167.50% |
| 2020-12-31 | CN¥449.37 Million | CN¥74.88 Million | 0.167x | -51.92% |
| 2019-12-31 | CN¥370.63 Million | CN¥128.45 Million | 0.347x | +464.79% |
| 2018-12-31 | CN¥276.37 Million | CN¥16.96 Million | 0.061x | -62.35% |
| 2017-12-31 | CN¥180.43 Million | CN¥29.41 Million | 0.163x | -- |